Real-world study shows improved anatomical outcomes in eyes treated with afl8, suggesting potential benefits for nAMD.
Our real-world study supports the potential short-term benefits of afl8 in improving anatomical and durability outcomes in patients with recurrent nAMD. These findings also highlight the added value of data-driven evaluations. Long-term studies are needed to confirm the effectiveness and durability of afl8 in this population.
No takes yet. Share an insight, caveat, or question.
Bartolomeo et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: